Necrotic Wounds

Necrotic wounds, defined by irreversibly nonviable tissue within a wound bed, present a complex clinical challenge across multiple care settings, including outpatient wound clinics, acute care hospitals, and burn centers. Necrosis impedes healing, fosters microbial colonization, and increases the risk of severe local and systemic complications. Understanding the risk factors, clinical features, underlying causes, treatment strategies, and complications associated with necrotic wounds is essential for optimizing patient outcomes.

Etiology of Necrotic Wounds

Necrotic tissue results from cell death due to inadequate perfusion, infection, or severe tissue injury, leading to failure of normal reparative processes. Local tissue ischemia is a major contributor, often arising from peripheral arterial disease (PAD), diabetes-associated vascular dysfunction, or prolonged pressure, which deprives tissue of oxygen and nutrients.^1-3 

Infections—particularly necrotizing soft tissue infections (NSTIs)—produce rapid tissue destruction via exotoxins and inflammatory mediators, resulting in extensive soft tissue necrosis.⁴ Traumatic injuries (burns, crush injuries, surgical wounds), chronic ulcers, and immune-mediated vasculopathies also contribute to necrotic wound development.^1-3

Risk Factors for Necrotic Wounds

Multiple systemic and local factors increase the risk of necrotic wounds:

Vascular disease. PAD impairs tissue perfusion, increasing susceptibility to ischemic necrosis.¹

Metabolic disorders. Diabetes mellitus predisposes patients to peripheral neuropathy, microvascular disease, and infection, which synergistically contribute to tissue breakdown.¹

Infection. Polymicrobial infections (including aerobic and anaerobic bacteria) and monomicrobial pathogens can precipitate necrotic processes in soft tissues.⁴

Immunosuppression. Chronic steroid use, malignancy, and other causes of immunocompromise diminish host defenses against infection and slow healing.

Pressure and shear. Immobility and biomechanical mechanisms may incite ischemia and subsequent necrosis in vulnerable areas.²

Age and comorbid conditions. Older age, malnutrition, and systemic diseases (eg, renal disease) further predispose to nonhealing necrotic wounds.

Necrotic Wound Clinical Presentation and Symptoms

Necrotic wounds typically manifest with visible nonviable tissue that appears black, brown, or dark and may be dry and leathery (eschar) or soft and moist (slough).¹ Surrounding tissues may demonstrate erythema, edema, and induration, particularly when infection is present.

Patients may report pain, although neuropathy can mask symptoms. Increased exudate, foul odor, delayed healing, and malodor are common features of necrotic wounds and often indicate bacterial proliferation within the wound bed.¹

In cases of necrotizing soft tissue infections (NSTIs), the clinical picture can include rapidly escalating pain disproportionate to physical findings, systemic toxicity (fever, tachycardia, hypotension), and signs of deep tissue involvement such as bullae, skin discoloration, and tissue crepitus.⁴ Delays in recognition are common and associated with worse outcomes.⁴

Diagnostic Considerations

Diagnosis of necrotic wounds involves thorough clinical assessment and may be supported by diagnostic studies when the etiology is unclear or systemic involvement is suspected. Tissue appearance, perfusion assessment (eg, Doppler studies, ankle-brachial index), and identification of infection are crucial. Laboratory studies can suggest systemic involvement (eg, leukocytosis, elevated inflammatory markers). Imaging may be indicated when deeper structures are involved or in suspected NSTIs but should not delay urgent management.⁴

Treatment Strategies for Necrotic Wounds

The management of necrotic wounds requires a multifaceted approach tailored to the underlying cause and extent of tissue involvement.

Debridement and necrotic wound bed preparation. Debridement of necrotic tissue is fundamental to wound bed preparation and is associated with improved wound healing potential. Removing necrotic tissue eliminates physical barriers to healing, reduces microbial load, and allows healthy tissue to proliferate. Expert consensus supports a range of debridement modalities (sharp, surgical, enzymatic, autolytic, biological) chosen based on patient factors, wound characteristics, and clinician expertise.⁵

Debridement modalities can be used in conjunction with one another to meet the goal. Leave dry, stable eschar intact.^2,6

For NSTIs, early and aggressive surgical debridement is the cornerstone of management and is associated with reduced morbidity and mortality. Repeated debridement may be necessary until viable tissue is present.⁴

Infection control. Prompt antimicrobial therapy is critical, particularly in necrotic wounds complicated by infection or NSTIs. Initiate broad-spectrum antibiotics empirically and tailor therapy according to culture results and clinical response.⁴ In NSTIs, initial broad coverage may include agents effective against gram-positive, gram-negative, and anaerobic organisms pending definitive microbiology.⁷ Evidence supports early antibiotic administration combined with surgical source control as standard practice.⁷

Adjunctive and supportive therapies. Adjunctive therapies that support wound healing may include negative pressure wound therapy (NPWT) to manage exudate and encourage granulation tissue formation, advanced dressings that balance moisture and protect the wound bed, and hyperbaric oxygen therapy in select cases, though data are heterogeneous.⁸ Optimization of perfusion (eg, revascularization for ischemic wounds), glycemic control in diabetes, pressure offloading, nutritional support, and management of comorbidities are essential components of comprehensive care.

Complications of Necrotic Wounds

Necrotic wounds are associated with multiple potential complications:

Infection. Necrotic tissue provides a nidus for bacterial growth, predisposing to cellulitis, abscess formation, and NSTIs if untreated.

Delayed healing and chronicity. Persistent necrotic tissue impedes normal wound progression, contributing to prolonged inflammation and stalled healing.¹

Tissue loss and amputation. Severe ischemia or infection may necessitate amputations or extensive reconstructive surgeries.

Systemic sequelae. Untreated infection can lead to sepsis, organ dysfunction, and increased mortality, particularly in NSTIs.⁴

Patients with extensive or deep necrotic wounds often require multidisciplinary care, including, but not limited to, surgical, infectious disease, and rehabilitation specialists to address the broad spectrum of clinical needs and minimize long-term disability.

Clinical Implications and Future Directions

Early identification and intervention are critical to improving outcomes in patients with necrotic wounds. Clinicians should maintain a high index of suspicion in high-risk populations and recognize early signs of necrosis and infection. Structured wound assessment tools and timely referral to specialized wound care or surgical teams may facilitate optimal management. Continued research is needed to refine diagnostic biomarkers, enhance wound healing techniques, and establish evidence-based protocols for adjunctive therapies.

References 
1. Tedesco S, Di Grezia M, Tropeano G, et al. Necrotizing soft tissue infections: a surgical narrative review. Updates Surg. 2025;77:1239-1251. doi:10.1007/s13304-025-02222-0 
2. Mayer DO, Tettelbach WH, Ciprandi G, et al. Best practice for wound debridement. J Wound Care. 2024;33(Sup6b):S1-S32. doi:10.12968/jowc.2024.33.Sup6b.S1
3. Stevens DL, Baddour LM. Necrotizing soft tissue infections. UpToDate. Published Feb. 27, 2024. Accessed Jan. 9, 2026. Available at https://www.uptodate.com/contents/necrotizing-soft-tissue-infections..&…;
4. McDermott J, Kao LS, Keeley JA, Grigorian A, Neville A, de Virgilio C. Necrotizing soft tissue infections: a review. JAMA Surg. 2024;159(11):1308-1315. doi:10.1001/jamasurg.2024.3365
5. Ousey K, Donnelly J, Dowsett C, et al. Expert consensus: Optimising debridement strategies for effective management of local wound infection. Wounds UK. Published 2025. Accessed Jan. 9, 2026. Available at https://wounds-uk.com/wp-content/uploads/2025/11/URG25_CD_Debridement_W….
6. Shamsian N. Wound bed preparation: an overview. British journal of community nursing. 2021 Sep 1;26(Sup9):S6-11. 
7. Charlier C, Souhail B, Dauger S, et al. Antibiotic therapy in necrotizing soft tissue infections: a narrative review of the greater Paris SURFAST consortium. Crit Care. 2025;29(1):431. Published 2025 Oct 10. doi:10.1186/s13054-025-05664-5 
8. Beraja GE, Gruzmark F, Pastar I, Lev-Tov H. What’s new in wound healing: treatment advances and microbial insights. Am J Clin Dermatol. 2025;26(5):677-694.